Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medicaid Work Requirements
  • ‘Skinny Labeling’
  • Gun Control
  • Suicide Prevention
  • Rural Health Payout

TRENDING TOPICS:

  • Medicaid Work Requirements
  • 'Skinny Labeling'
  • Gun Control
  • Suicide Prevention
  • Rural Health Payout

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, May 30 2018

Full Issue

Perspectives: Drug Companies Placing Higher Priority On Profits Than The Lives They Could Be Saving

Read recent commentaries about drug-cost issues.

Ventura County Star: Let Medicare Corral Drug Prices

The latest example of runaway drug pricing has pitted the industrial town of Rockford, Illinois, against specialty drug manufacturer Mallinckrodt Pharmaceuticals. Rockford, with fewer than 150,000 residents, accuses Mallinckrodt of price gouging and another local company, Express Scripts, of failing to fairly negotiate drug prices. No matter what justification drug companies offer for outlandish pricing, there’s no escaping the higher priority they place on profits over saving lives and easing human suffering. (5/27)

The Wall Street Journal: Why CVS Loves ObamaCare

Big business feasts on big government, and ObamaCare has been a bonanza for companies that have figured out how to exploit it. Witness how CVS Health is dining out on Ohio’s Medicaid expansion. In addition to retail pharmacies, CVS operates a pharmaceutical benefit manager (PBM) that acts as a middleman between insurers, pharmacies and drug manufacturers. PBMs decide which drugs are listed on a formulary, how much pharmacies are reimbursed and how much insurers pay. (5/29)

Forbes: Good News For Patients: Trump Won't Dramatically Lower Drug Prices

Pharma was relieved, Wall Street unimpressed and many in the political arena disappointed when, after much chest thumping, the president who “keeps his promises” came out with a surprisingly benign drug pricing policy. Compared to the Arab-Israeli conflict, Iran, China, global warming and the leadership of the free world, pharma seems a small target with a potentially large payoff. Why did the disrupter-in-chief settle for fine-tuning the drug market that everybody (other than pharma CEOs) hates? (Standish Fleming, 5/24)

Fox News: How Medicare-Medicaid Chief Seema Verma's Taking Steps To Sink Drug Prices Under Trump's Plan

President Trump is taking effective action to lower prescription drug prices and to improve the American health-care delivery system, Medicare and Medicaid Administrator Seema Verma told me recently in an exclusive on-camera interview for Fox News. The president is “not afraid of special interests,” Verma said. (Marc Siegel, 5/29)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF